Lewis, Sarah SSmith, Becky AAkinboyo, Ibukunoluwa CSeidelman, JessicaWolfe, CameronKirk, Allan BMartin, GavinDenny, ThomasLobaugh, BruceRehder, CatherineCardona, DianaLee, Mark JPolage, Christopher RDatto, Michael B2021-01-042021-01-042020-08-030899-823X1559-6834https://hdl.handle.net/10161/21993We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area.Journal article2021-01-04